BACKGROUND: Studies of resource utilization by patients with new-onset atrialfibrillation after coronary artery bypass grafting have addressed only length of stay and bed charges. OBJECTIVE: To compare resource utilization between patients with new-onset atrial fibrillation and patients without atrialfibrillation after isolated coronary artery bypass grafting. METHODS: Retrospective review of clinical and administrative electronic databases for 720 subjects who underwent isolated coronary artery bypass grafting with cardiopulmonary bypass in 25 months at one medical center The prevalence of atrial fibrillation was determined, and resource utilization in various hospital cost centers was compared between subjects with and without atrialfibrillation. RESULTS: The prevalence of new-onset atrial fibrillation was 33.1%. Compared with subjects without atrialfibrillation, subjects with atrialfibrillation had a longer stay (5.8 +/- 2.4 vs. 4.4+/-1.2 days, P<.001), more days receiving mechanical ventilation (P =.002) and oxygen therapy (P<.001), and higher rates of readmission to the intensive care unit (4.6% vs. 0.2%, P<.001). Subjects with atrial fibrillation also had more laboratory tests (P<.001) and more days receiving cardiac drugs, heparin, diuretics, and electrolytes. Subjects with atrialfibrillation had higher total postoperative charges ($57261 +/- $17101 vs. $50905 +/- $10062, P = .001), a mean difference of $6356. The mean differences were greatest for bed charges ($1642), laboratory charges ($1215), pharmacy ($989), and respiratory care ($582). CONCLUSION: The economic impact of atrialfibrillation after coronary artery bypass grafting has been underestimated.
BACKGROUND: Studies of resource utilization by patients with new-onset atrialfibrillation after coronary artery bypass grafting have addressed only length of stay and bed charges. OBJECTIVE: To compare resource utilization between patients with new-onset atrial fibrillation and patients without atrialfibrillation after isolated coronary artery bypass grafting. METHODS: Retrospective review of clinical and administrative electronic databases for 720 subjects who underwent isolated coronary artery bypass grafting with cardiopulmonary bypass in 25 months at one medical center The prevalence of atrial fibrillation was determined, and resource utilization in various hospital cost centers was compared between subjects with and without atrialfibrillation. RESULTS: The prevalence of new-onset atrial fibrillation was 33.1%. Compared with subjects without atrialfibrillation, subjects with atrialfibrillation had a longer stay (5.8 +/- 2.4 vs. 4.4+/-1.2 days, P<.001), more days receiving mechanical ventilation (P =.002) and oxygen therapy (P<.001), and higher rates of readmission to the intensive care unit (4.6% vs. 0.2%, P<.001). Subjects with atrial fibrillation also had more laboratory tests (P<.001) and more days receiving cardiac drugs, heparin, diuretics, and electrolytes. Subjects with atrialfibrillation had higher total postoperative charges ($57261 +/- $17101 vs. $50905 +/- $10062, P = .001), a mean difference of $6356. The mean differences were greatest for bed charges ($1642), laboratory charges ($1215), pharmacy ($989), and respiratory care ($582). CONCLUSION: The economic impact of atrialfibrillation after coronary artery bypass grafting has been underestimated.
Authors: L Frost; C J Jacobsen; E H Christiansen; H Mølgaard; H Pilegaard; K Hjortholm; P E Thomsen Journal: Acta Anaesthesiol Scand Date: 1995-07 Impact factor: 2.105
Authors: S F Aranki; D P Shaw; D H Adams; R J Rizzo; G S Couper; M VanderVliet; J J Collins; L H Cohn; H R Burstin Journal: Circulation Date: 1996-08-01 Impact factor: 29.690
Authors: L A Mendes; G P Connelly; P A McKenney; P J Podrid; L A Cupples; R J Shemin; T J Ryan; R Davidoff Journal: J Am Coll Cardiol Date: 1995-01 Impact factor: 24.094
Authors: Benjamin A Steinberg; Yue Zhao; Xia He; Adrian F Hernandez; David A Fullerton; Kevin L Thomas; Roger Mills; Winslow Klaskala; Eric D Peterson; Jonathan P Piccini Journal: Clin Cardiol Date: 2013-12-18 Impact factor: 2.882
Authors: J Hunter Mehaffey; Robert B Hawkins; Matthew Byler; Judy Smith; John A Kern; Irving Kron; Gorav Ailawadi; Tanya Wanchek; Leora T Yarboro Journal: Ann Thorac Surg Date: 2018-01-31 Impact factor: 4.330
Authors: Dariush Mozaffarian; Roberto Marchioli; Alejandro Macchia; Maria G Silletta; Paolo Ferrazzi; Timothy J Gardner; Roberto Latini; Peter Libby; Federico Lombardi; Patrick T O'Gara; Richard L Page; Luigi Tavazzi; Gianni Tognoni Journal: JAMA Date: 2012-11-21 Impact factor: 56.272